Yunjiang Liu
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Topics
- HER2/EGFR in Cancer Research (13 papers)Breast Cancer Treatment Studies (12 papers)Advanced Breast Cancer Therapies (11 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yunjiang Liu
53 papers receiving 803 citations
Peers
Comparison fields: 5 of 76
- Oncology 517
- Pulmonary and Respiratory Medicine 235
- Cancer Research 188
- Molecular Biology 186
- Radiology, Nuclear Medicine and Imaging 154
Countries citing papers authored by Yunjiang Liu
This map shows the geographic impact of Yunjiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunjiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunjiang Liu more than expected).
Fields of papers citing papers by Yunjiang Liu
This network shows the impact of papers produced by Yunjiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunjiang Liu. The network helps show where Yunjiang Liu may publish in the future.
Co-authorship network of co-authors of Yunjiang Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Yunjiang Liu. A scholar is included among the top collaborators of Yunjiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunjiang Liu. Yunjiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 19 | |
| 5 | The Safety of Neoadjuvant Therapy with Polyethylene Glycol Liposome Adriamycin Combined with Docetaxel in Patients with Breast Cancer Complicated by Axillary Lymph Node Metastasis. | 0 |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 15 | |
| 10 | 2 | |
| 11 | 4 | |
| 12 | 4 | |
| 13 | 9 | |
| 14 | 15 | |
| 15 | 12 | |
| 16 | 247 | |
| 17 | 43 | |
| 18 | 25 | |
| 19 | 28 | |
| 20 | 3 |
About Yunjiang Liu
Yunjiang Liu is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 813 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Breast Cancer Treatment Studies (12 papers) and Advanced Breast Cancer Therapies (11 papers). The work is most often cited by research in Oncology (517 citations), Cancer Research (188 citations) and Pulmonary and Respiratory Medicine (235 citations). Yunjiang Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Binghe Xu, Fei Ma, Wěi Li, Xiangmei Zhang, Xiaoyu Zhu, Zefei Jiang, Quchang Ouyang, Shusen Wang, Jianjun Zou and Huiping Li. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.